Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
European Archives of Oto-Rhino-Laryngology
Published in: European Archives of Oto-Rhino-Laryngology 8/2018

Open Access 01-08-2018 | Rhinology

The role of oral anticoagulants in epistaxis

Authors: A. M. S. Buchberger, A. Baumann, F. Johnson, N. Peters, G. Piontek, K. Storck, A. Pickhard

Published in: European Archives of Oto-Rhino-Laryngology | Issue 8/2018

Login to get access

Abstract

Purpose

The purpose of this retrospective study was to identify the impact of oral anticoagulants on epistaxis with the focus on new oral anticoagulants.

Methods

The study was conducted at the Department  for Ear- Nose- and Throat (ENT), Head and Neck Surgery, Technical University Munich, Germany. All patients presenting in 2014 with the diagnosis of epistaxis to a specialized ENT accident and emergency department were identified and analyzed in clinical data and medication.

Results

600 adult cases, with a median age of 66.6 years were identified with active bleeding. 66.8% of all cases were anticoagulated. Classic oral anticoagulants (COAC) were three times more common in patients than new-generation oral anticoagulants (NOAC). Recurrent bleeding was significantly associated with oral anticoagulants (OAC) (p = 0.014) and bleeding location was most often anterior (p = 0.006). In contrast, severe cases, which required surgery or embolization were significantly more likely in non-anticoagulated middle-aged patients with posterior bleedings (p < 0.05). In our epistaxis cohort, OAC were highly overrepresented (40%) when compared to the general German population (1%) but COAC as well as NOAC played only a minor role in severe courses of epistaxis.

Conclusion

Oral anticoagulation, especially with new-generation drugs, is not associated with more complicated and severe courses of epistaxis, but rather with recurrent bleeding. One should keep this information in mind when triaging the patient in the emergency room and when planning further procedures.
Literature
1.
Viehweg TL, Roberson JB, Hudson JW (2006) Epistaxis: diagnosis and treatment. J Oral Maxillofac Surg 64(3):511–518CrossRefPubMed
2.
Spielmann PM, Barnes ML, White PS (2012) Controversies in the specialist management of adult epistaxis: an evidence-based review. Clin Otolaryngol 37(5):382–389CrossRefPubMed
3.
Walker TW, Macfarlane TV, McGarry GW (2007) The epidemiology and chronobiology of epistaxis: an investigation of Scottish hospital admissions 1995–2004. Clin Otolaryngol 32(5):361–365CrossRefPubMed
4.
Douglas R, Wormald PJ (2007) Update on epistaxis. Curr Opin Otolaryngol Head Neck Surg 15(3):180–183CrossRefPubMed
5.
Rubboli A, Becattini C, Verheugt FW (2011) Incidence, clinical impact and risk of bleeding during oral anticoagulation therapy. World J Cardiol 3(11):351–358CrossRefPubMedPubMedCentral
6.
Suzuki S, Otsuka T, Sagara K et al (2016) Nine-year trend of anticoagulation use, thromboembolic events, and major bleeding in patients with non-valvular atrial fibrillation- shinken database analysis. Circ J 80(3):639–649CrossRefPubMed
7.
Glaeske G, Schicktanz C (2015) Barmer GEK Krankenkasse—pharmacy report 2015. Siegburg Asgard- Verl.- Serv (ISBN: 978-3-943744-97-2)
8.
Chang HY, Zhou M, Tang W, Alexander GC, Singh S (2015) Risk of gastrointestinal bleeding associated with oral anticoagulants: population based retrospective cohort study. BMJ 350:h1585CrossRefPubMedPubMedCentral
9.
Abraham NS, Singh S, Alexander GC et al (2015) Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study. BMJ 350:h1857CrossRefPubMedPubMedCentral
10.
Villwock JA, Jones K (2013) Recent trends in epistaxis management in the United States: 2008–2010. JAMA Otolaryngol Head Neck Surg 139(12):1279–1284CrossRefPubMed
11.
12.
Melia L, McGarry G (2008) Epistaxis in adults: a clinical review. Br J Hosp Med (Lond) 69(7):404–407CrossRef
13.
Cullen MM, Tami TA (1998) Comparison of internal maxillary artery ligation versus embolization for refractory posterior epistaxis. Otolaryngol Head Neck Surg 118(5):636–642PubMed
14.
Supriya M, Shakeel M, Veitch D, Ah-See KW (2010) Epistaxis: prospective evaluation of bleeding site and its impact on patient outcome. J Laryngol Otol 124(7):744–749CrossRefPubMed
15.
Bolz M, Streppel M, Guntinas-Lichius O (2011) The impact of a university ENT emergency centre for the ambulatory care of ENT emergency patients. Laryngorhinootologie 90(1):17–22CrossRefPubMed
16.
Soyka MB, Nikolaou G, Rufibach K, Holzmann D (2011) On the effectiveness of treatment options in epistaxis: an analysis of 678 interventions. Rhinology 49(4):474–478PubMed
17.
Schwabe U, Paffrath D (2012) Pharmaceutical prescription 2012. Springer, Berlin
18.
Bermüller C, Bender M, Brögger C, Petereit F, Schulz M (2014) Epistaxis and anticoagulation—a medical and economic challenge?. Laryngorhinootologie 93(4):249–255PubMed
19.
Smith J, Siddiq S, Dyer C, Rainsbury J, Kim D (2011) Epistaxis in patients taking oral anticoagulant and antiplatelet medication: prospective cohort study. J Laryngol Otol 125(1):38–42CrossRefPubMed
20.
Soyka MB, Rufibach K, Huber A, Holzmann D (2010) Is severe epistaxis associated with acetylsalicylic acid intake? Laryngoscope 120(1):200–207PubMed
21.
Kikidis D, Tsioufis K, Papanikolaou V, Zerva K, Hantzakos A (2014) Is epistaxis associated with arterial hypertension? A systematic review of the literature. Eur Arch Otorhinolaryngol 271(2):237–243CrossRefPubMed
22.
Herkner H, Havel C, Müllner M et al (2002) Active epistaxis at ED presentation is associated with arterial hypertension. Am J Emerg Med 20(2):92–95CrossRefPubMed
23.
Mancia G, Fagard R, Narkiewicz K et al. (2013) ESH/ESC Task Force for the Management of Arterial Hypertension. 2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension. J Hypertens 31(10):1925–1938CrossRef
24.
Barnes ML, Spielmann PM, White PS (2012) Epistaxis: a contemporary evidence based approach. Otolaryngol Clin N Am 45(5):1005–1017CrossRef
25.
Ciurus T, Sobczak S, Cichocka-Radwan A, Lelonek M (2015) New oral anticoagulants—a practical guide. Kardiochir Torakochirurgia Pol 12(2):111–118. doi: 10.5114/kitp.2015.52851. (Epub 2015 Jun 30. PubMed PMID: 26336492; PubMed Central PMCID: PMC4550032) PubMedPubMedCentral
26.
McClurg SW, Carrau R (2014) Endoscopic management of posterior epistaxis: a review. Acta Otorhinolaryngol Ital 34(1):1–8PubMedPubMedCentral
Metadata
Title
The role of oral anticoagulants in epistaxis
Authors
A. M. S. Buchberger
A. Baumann
F. Johnson
N. Peters
G. Piontek
K. Storck
A. Pickhard
Publication date
01-08-2018
Publisher
Springer Berlin Heidelberg
Published in
European Archives of Oto-Rhino-Laryngology / Issue 8/2018
Print ISSN: 0937-4477
Electronic ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-018-5043-z

Other articles of this Issue 8/2018

European Archives of Oto-Rhino-Laryngology 8/2018 Go to the issue

Head & Neck

The diagnostic value of TROP-2, SLP-2 and CD56 expression in papillary thyroid carcinoma

Head & Neck

Factors contributing to surgical site infection in patients with oral cancer undergoing microvascular free flap reconstruction

Otology

Parameters of skull vibration-induced nystagmus in normal subjects

Otology

Preservation of the facial and lower cranial nerves in glomus jugulare tumor surgery: modifying our surgical technique for improved outcomes

Head & Neck

Histogram analysis of apparent diffusion coefficient maps for differentiating malignant from benign parotid gland tumors

Head and Neck

Early effects of irradiation on laryngeal mucosa in a gastroesophageal reflux model: an experimental study